key: cord-0915223-nnlwg7ok
authors: Wink, P. L.; Volpato, F.; Lima-Morales, D.; Paiva, R. M.; Willig, J. B.; Bock, H.; de-Paris, F.; Barth, A. L.
title: RT-qPCR half reaction optimization for the detection of SARS-CoV-2
date: 2021-05-21
journal: nan
DOI: 10.1101/2021.05.19.21257470
sha: 14c7d6097edf9293e6d1ee8caf0fd306b8b94de5
doc_id: 915223
cord_uid: nnlwg7ok

BACKGROUND: The main laboratory test for the diagnosis of COVID-19 is the reverse transcription real-time polymerase chain reaction (RT-qPCR). However, the RT-qPCR is an expensive method due to the number of tests required. OBJECTIVES: To evaluate an alternative RT-qPCR approach for the detection of SARS-CoV-2 sing half of the total volume currently recommended by the US Centers for Disease Control and Prevention. METHODS: The analytical limit of detection (LoD) and the reaction efficiency using half volumes of RT-qPCR assay were evaluated for both the N1 and N2 regions by using a synthetic control RNA. A panel of 76 SARS-CoV-2-positive and 26 SARS-CoV-2-negative clinical samples were evaluated to establish the clinical sensitivity and specificity. FINDINGS: The RT-qPCR assay efficiency was 105% for both the half and standard reactions considering the N2 target and 84% (standard) and 101% (half) for N1. The RT-qPCR half reaction LoD for N1 and N2 were 20 and 80 copies/uL, respectively. Clinical sensitivity and specificity were 100%. The half reaction presented a decrease of up to 5.5 cycle thresholds when compared with the standard RT-qPCR. CONCLUSIONS: The use of RT-qPCR half reaction proved to be a feasible and economic strategy for detection of SARS-CoV-2 RNA.

parallel using the SuperScript™ III One-Step RT-PCR System (Thermo Fisher 18 Scientific, Massachusetts, EUA). A description of the RT-qPCR assay is available 19 at the CDC Laboratory Information website for . Briefly, to perform 20 the standard RT-qPCR reaction, 5 μL isolated RNA sample was mixed with 15 21 μL of one-step RT-qPCR mix containing 10 μL of 2X Master Mix, 0.4 μL of 22

Platinum enzyme, 1.5 μL each of 10 μM combined primer/probe mix, 0.4 μL of 23 2.5 μM ROX passive reference dye, 2.7 μL of water, and 5 μL of nucleic acid 24 extract. For the RT-qPCR half reaction, half of the volumes of the reagents listed 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101 /10. /2021 above were used, without adding water to the mixture. Therefore, our proposed 1 reaction included 6 μL of reagents plus 4 μL of RNA, totaling 10 μL in each well, 2 resulting in a reaction with more template RNA in relation to the reaction mixture 3 (4-6 μL compared to 5-15 μL from the standard RT-qPCR reaction). 4

We used three control samples in each RT-qPCR run: a positive template 5 control, water as a negative control, and an internal control (human ribonuclease 6 P gene, RNAse P). We conducted both of the assays (standard reaction and the 7 half reaction) in 96-well plates using an Applied Biosystems QuantStudio Real-8

Time PCR 3 Instrument (Thermo Fisher Scientific, Massachusetts, EUA). Cycling 9 conditions consisted of 30 min at 50°C for reverse transcription, 2 min at 95°C for 10 activation of the Platinum enzyme, and 45 cycles of 15 s at 95°C and 35 s at 11 55°C. We used the threshold automatically established by the equipment. 12

A cycle threshold (Ct) value lower than 40 for N1 and N2 targets was 13 reported as PCR positive. The result was considered negative if the Ct was 14 undetectable or greater than 40. The RNAse P was used to monitor nucleic acid 15 extraction, specimen quality and presence of reaction inhibitors. 16 17

Assay specificity was determined using high-titer virus stock as well as 19 clinical samples positive for SARS-CoV-2 using the standard RT-qPCR assay in 20 a Quant Studio Real-Time PCR system (Thermo Fischer Scientific, 21

Massachusetts, EUA). The reaction efficiency was validated for N1 and N2 22 targets using a standard curve with five points with a serial dilution (from 1 x 10 5 23 to 10 copies/µL) of a synthetic control RNA (Integrated DNA Technologies, 24

Coralville, IA, USA) in triplicate. The data of the Ct values of the serial dilutions 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101 /10. /2021 were plotted against the target concentration (number of the virus copies). We 1 determined the slope of the curve by linear regression and defined the required 2 levels for PCR efficiency ([100 x 10 (-1/slope) -1]) and linearity (R 2 ) of each RT-qPCR 3 target to be 90-110% and >0.95, respectively (7). 4 5

To determine the analytical limit of detection (LoD) of the RT-qPCR half 7 reaction assay, we tested 1, 5, 10, 20, 50, 80 , and 100 copies of SARS-CoV-2 8 RNA per μL. The LoD of N1 and N2 targets were independently assessed using 9 serially diluted synthetic control RNA. The calibration curve for the genomic copy 10 number versus Ct value was obtained from the Quant Studio RT-qPCR 11 instrument (Thermo Fischer Scientific, Massachusetts, EUA). A series of 20 12 parallel reactions per concentration step was prepared and tested by Assay reproducibility was tested using replicated dilutions of the RNA 14 transcripts and intra-and inter-assay variability was evaluated for each dilution 15 point on different days. 16 17

A total of 102 clinical samples from different patients attending at "Hospital 19 de Clínicas de Porto Alegre" in Southern Brazil were obtained by 20 oro/nasopharyngeal swabbing. All samples were submitted to analysis using the 21 standard and the half reaction protocols described above. 22 23

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101 /10. /2021 The study was approved by the Ethics Committees from Hospital de 1

Clínicas de Porto Alegre (CAAE: 30767420.2.0000.5327). 2 3 3. Results 4 5

The reaction efficiency using half of the volume was evaluated for both N1 7 and N2 regions in comparison to the standard RT-qPCR reaction by using a 8 synthetic control RNA. The RT-qPCR efficiencies regarding the half reaction were 9 101.2% and 105.7% for N1 and N2 targets, respectively. Conversely, for the 10 standard RT-qPCR reaction, the efficiency values were 84.4% (N1) and 104.7% 11 (N2) ( Table 1 ). The R 2 for each target was found to be higher than 0.95 for both 12 reactions ( Figure 1 ). 13

Although we planned to generate efficiency curves for both the RT-qPCR 14 half and standard reactions using five dilution points for both targets (N1 and N2), 15 this was only possible for the N1 target. Due to the LoD of the N2 target, we were 16 able to obtain a Ct value for only four dilution points (from 1 x 10 5 to 1 x 10 2 17 copies/µL). 18 19

Serial dilutions of the nucleocapsid RNA transcripts were tested to assess 21 the detection limits and dynamic range of the RT-qPCR assays. The lower LoD 22 was 20 transcript copies per reaction for the N1 target, and 80 copies per reaction 23

for the N2 target. 24 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101 /10. /2021 At these lower copy detection limits for the N1 and N2 targets, assay 1 reproducibility was 95% and 100%, respectively. Eighty-five percent 2 reproducibility was achieved at the dilution that contained 10 transcript copies per 3 reaction with the N1 target and at the 50 transcript copies per reaction dilution 4 with the N2 target. values was 0.7 and 2.8 for N1 and N2 targets, respectively, when compared to 19 the standard RT-qPCR (Table 2) . 20

Twelve isolates with an increase in Ct value for the N1 target (average 0.4) 21 and 2 isolates for the N2 target (0.1) were observed for the half RT-qPCR assay 22 when compared to the standard reaction. Nine isolates did not present a 23 difference in the values of Ct for N1 and only one for the N2 target. 24 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

We evaluated RT-qPCR using half of the total reaction volume currently 2 recommended by the US CDC protocol to detect SARS-CoV-2. Whether or not 3 the half reaction assay proved to be a reliable method to detect the RNA of SARS-4

CoV-2, it would save consumables. The RT-qPCR half reaction efficiency was 5 equivalent to the standard RT-qPCR reaction for the N2 target. Moreover, we 6 observed an important increase in efficiency (from 84.4% to 101.2%) for the N1 7 target using the RT-qPCR half reaction. The LoD for N1 and N2 was also 8 evaluated for the RT-qPCR half reaction assay and the results demonstrated that 9 N1 is more sensitive than N2 (LoD = 20 and 80 copies/µL, respectively). 10

These data show that the reduction in the reaction approach has no 11 influence on the quality of the results; unexpectedly, an increase in sensitivity and 12 efficiency was observed. When we compared the Ct values of the SARS-CoV-2 13 positive clinical samples obtained by the two assays, we observed a decrease in 14 the values of Ct for most samples, either for the N1 (55 cases -72%) or N2 (73 15 cases -96%) targets in the half RT-qPCR assay. These findings indicate that the 16 half reaction assay presents a better yield than the standard reaction. It is 17 possible that the ratio of RNA to reaction mixture could have an influence on the 18 sensitivity of the RT-qPCR. Furthermore, the comparison of Ct values of the two 19

reaction approaches with clinical samples shows the kinetics of sensitivity 20 depending on the viral load using the Ct value. The lower the Ct, the lower the 21 differences between the approaches (Table 2) . 22

Although RT-qPCR assays remain the molecular test of choice for the 23 diagnosis of SARS-CoV-2 infection, considerable efforts have been made to 24 improve the detection of coronavirus and a variety of improved or new 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101 /10. /2021 approaches have been developed. Since the RT-qPCR methods require time-1 consuming sample handling and post-PCR analysis, immunoassays have been 2 developed for the rapid detection of SARS-CoV-2 antigens or antibodies (IgM 3 and IgG) against COVID-19. They would theoretically provide the advantage of a 4 fast time to results and the low-cost detection of SARS-CoV-2, but are likely to 5 suffer from poor sensitivity in the early infection period (8). 6

To enable massive coronavirus testing, the pooling of clinical samples was 7

proposed as a testing strategy that would significantly increase the testing 8 capacity of laboratories (9,10). However, the use of pools would be much more 9 effective to test clinical samples in scenarios of the low prevalence of SARS-CoV-10 2 as a positive result for the pool would require all samples to be tested 11 individually (9,10). Furthermore, as previously described, considering that the 12 concentrations of RNA had been reduced in the pooled specimens, the Ct values 13 were expected to increase by five Ct values compared with single samples (9). 14 Accordingly, pools with a high number of samples (30 samples) may present 15 false-negative results in the RT-qPCR for SARS-CoV-2, especially when a 16 positive sample has a higher Ct (9). 17 18

The present study optimized the RT-qPCR method for the detection of SARS-20

CoV-2, with the half reaction presenting a better performance with higher 21 sensitivity and specificity compared to the standard reaction. Importantly, in view 22 of the RT-qPCR reaction being frequently used worldwide at present, it is a huge 23 advantage to adapt this protocol in the routine of molecular diagnostic 24 laboratories, as it is essential for economic purposes to save reagents and 25 increase the number of patients able to be tested for COVID-19 disease 1 worldwide. Moreover, decreasing the total reagent volume and increasing the 2 template concentration inside the reaction assay for a single run would be very 3 useful to increase test sensitivity. In light of the current situation, a one-step PCR 4 protocol achieving both high sensitivity and specificity is beneficial for facing the 5 SARS-CoV-2 pandemic. 6 7 Acknowledgements 8

We thank the staff of "Laboratório de Diagnóstico de SARS-CoV-2" as well as the 9 staff of the Hospital Infection Committee of our institution ("Hospital de Clínicas 10 de Porto Alegre") for providing data used in this study. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101 /10. /2021 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101 /10. /2021 

COVID-19): A Review

Report from the American Society for 14

Diagnostic Testing for SARS-CoV-2/COVID-19. mBio

Detection of 2019 novel 23 coronavirus (2019-nCoV) by real-time RT-PCR

All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101/2021.05.19 (Accessed July 27th, 2020). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101 /10. /2021 10. Volpato F., Lima-Morales D., Wink P.L., Willig J., de-Paris F., Ashton-1 Prolla P., Barth A.L. 2020. Pooling of samples to optimize SARS-CoV-2 2 diagnosis by RT-qPCR: comparative analysis of two protocols. Eur. J. Clin. 3Microbiol. Infect. Dis. 16, 1-4. https://doi.org/10.1007/s10096-020-04071-4

All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101 /10. /2021 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Eff%, curve efficiency. 4 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org /10.1101 /10. /2021